News

1

DolPHIN-2 presents on depressive symptoms at CROI 2024

Prof Saye Khoo recognised in UK New Years Honours

DolPHIN-2 publishes the final results

DolPHIN-2 publishes qualitative research on DTG rollout

DolPHIN-2 publishes trial primary outcome

DolPHIN-2 presents on postpartum weight changes at CROI 2020

The Ugandan Team Celebrates World Breastfeeding Week

DolPHIN-2 presents primary outcome analysis at CROI 2019

DolPHIN-2 Study team's response to WHO's statement on the safety of dolutegravir in pregnancy

WHO released a statement on 18 May 2018 relating to a potential safety issue affecting women living with HIV using dolutegravir at the time of conception.

DolPHIN 2 Trial Manager and Trial Monitor to visit Cape Town site

The DolPHIN 2 trial opened for recruitment in our South African site last month.

The first participant has been recruited to the DolPHIN 2 trial!

On 22nd January 2018, our South African site opened to recruitment with the very first participant recruited into the DolPHIN-2 clinical trial the very next day.

The Liverpool team sets off for Uganda: IDI Site Initiation Visit

Today marks an important step in the set-up of the DolPHIN 2 trial, as key members of the Liverpool team make their way to Uganda for a Site Initiation Visit (SIV).